Clinical Trials Directory

Trials / Completed

CompletedNCT01561625

Signaling Pathway Activation After Exercise in Patients With Chronic Obstructive Pulmonary Disease

Signaling Pathway Activation in the Quadriceps of Patients With COPD After an Acute Bout of Resistance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Laval University · Academic / Other
Sex
Male
Age
50 Years – 75 Years
Healthy volunteers
Accepted

Summary

Muscle weakness and atrophy are important consequences of chronic obstructive pulmonary disease (COPD). Although resistance exercises increase strength and muscle mass in patients with COPD, the response to training appears to be suboptimal in these individuals. A dysregulation in the signaling pathways involved in the regulation of muscle mass could play an important role in this phenomenon. Hypothesis: Proteins involved in muscle mass regulation will be less activated in the quadriceps of patients with COPD following the acute bout of resistance training exercise compared to healthy age-matched controls.

Detailed description

Our objective is to investigate the impact of an acute bout of resistance training on key signaling pathways involved in the regulation of muscle mass in moderate to severe COPD (FEV1 under 60% of predicted). Key proteins of signaling intramuscular pathways involved in protein synthesis and degradation will be measured before after 72 contractions of the quadriceps. The exercise protocol was designed to match the actual exercise prescription model use in the context of pulmonary rehabilitation. A squat, leg press and leg extension will be done at 80% of max with one minute rest between sets. A biopsy of the quadriceps will be done before and after exercise in order to measure phosphorylated kinases, total protein content and mRNA expressions. All our patients will undergo a thorough baseline assessment in pulmonary capacity, muscle force and body composition.

Conditions

Interventions

TypeNameDescription
OTHERexerciseresistance training exercise, 1 session, 3 exercises, 80% of max

Timeline

Start date
2009-10-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2012-03-23
Last updated
2013-05-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01561625. Inclusion in this directory is not an endorsement.